China Initiates Commercial Trials for Genetically Modified Soy and Corn
China is making significant strides in expanding its commercial trial plantings of genetically modified (GM) corn and soybeans, aiming to enhance production efficiency and reduce costs, writes Blake Herzog at AgriBusiness Global DIRECT.
Despite concerns among citizens regarding perceived health risks associated with GM crops, the government plans to scale up production in 2024, with the eventual authorization for these crops to enter the commercial market in the coming years.
Find out how analysts project that GM crops will become a significant presence in China.
Read the full article on ABG Direct.
Vylor to Expand Soybean Leadership: Next-Gen Tech Platforms Maintain North America Yield Advantage, Accelerate Latin America Lineup via Broad Spectrum Insect Control
AgriBusiness Global connects the crop input value chain from raw material manufacturers down to distributors and trading partners around the world. Our content empowers smarter sourcing and business decisions by providing key insights to buyers and sellers of crop inputs including crop protection (both traditional agrochemical and biocontrol) and plant health products (including fertilizers, biostimulants, macro and micronutrients). See all author stories here.